A new study by researchers at CVS Health and Brigham and Women's Hospital found that patients who took a generic statin were more likely to be adherent to their medication than those starting on a branded drug.
Mylan announced that its subsidiary, Mylan Labs Limited, has signed an agreement with Gilead Science under which Mylan has been licensed the non-exclusive rights to manufacture and distribute sofosbuvir and the investigational single-tablet regimen of ledipasvir/sofosbuvir in 91 developing countries.
Lupin Limited and Salix Pharmaceuticals on Friday announced that they have entered into a definitive distribution agreement under which Salix has granted Lupin the exclusive right to market, distribute and sell certain Salix products in Canada.
Close to 100 million wearable, remote patient-monitoring devices will ship over the next five years, according to ABI Research, boosted by growing interest and awareness about the benefits of supporting healthcare away from the hospital and into patients’ homes.
The National Association of Boards of Pharmacy last week launched the .pharmacy generic Top-Level Domain (gTLD) to provide consumers a means for identifying safe, legal and ethical online pharmacies and related resources.
The Ohio-based start-up C2B Solutions is available to provide key healthcare consumer insights and strategy to help healthcare companies more effectively influence patient behavior, the company announced last week.
Mylan announced that its subsidiary, Mylan Ireland Limited, has agreed to acquire the U.S. rights relating to Arixtra (fondaparinux sodium) injection and the authorized generic version of Arixtra from Aspen Global.